|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 80.15 EUR | +0.94% |
|
+0.94% | +1.89% |
| Apr. 02 | Bernstein starts AstraZeneca at 'outperform' | AN |
| Feb. 22 | Transcript : Kerry Group plc Presents at 2024 Consumer Analyst Group of New York Conference, Feb-22-2024 10:00 AM |
Kerry Group plc reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EUR 8,020.3 million compared to EUR 8,771.9 million a year ago. Net income was EUR 728.3 million compared to EUR 606.4 million a year ago.
Basic earnings per share from continuing operations was EUR 4.104 compared to EUR 3.419 a year ago. Diluted earnings per share from continuing operations was EUR 4.097 compared to EUR 3.413 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +1.89% | 14.85B | |
| -4.93% | 261B | |
| -2.51% | 94.98B | |
| +3.19% | 46.39B | |
| +8.74% | 39.99B | |
| -0.65% | 39.95B | |
| -0.15% | 38.02B | |
| -16.78% | 30.16B | |
| -6.61% | 28.72B | |
| +11.32% | 24.54B |
KERRY GROUP PLC 
